Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

985 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia.
Yoshida M, Nakabayashi K, Yang W, Sato-Otsubo A, Tsujimoto SI, Ogata-Kawata H, Kawai T, Ishiwata K, Sakamoto M, Okamura K, Yoshida K, Shirai R, Osumi T, Moriyama T, Nishii R, Takahashi H, Kiyotani C, Shioda Y, Terashima K, Ishimaru S, Yuza Y, Takagi M, Arakawa Y, Kinoshita A, Hino M, Imamura T, Hasegawa D, Nakazawa Y, Okuya M, Kakuda H, Takasugi N, Inoue A, Ohki K, Yoshioka T, Ito S, Tomizawa D, Koh K, Matsumoto K, Sanada M, Kiyokawa N, Ohara A, Ogawa S, Manabe A, Niwa A, Hata K, Yang JJ, Kato M. Yoshida M, et al. Among authors: hino m. Blood Adv. 2021 Dec 14;5(23):5420-5428. doi: 10.1182/bloodadvances.2021005507. Blood Adv. 2021. PMID: 34662904 Free PMC article.
Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers.
Aoki T, Hino M, Koh K, Kyushiki M, Kishimoto H, Arakawa Y, Hanada R, Kawashima H, Kurihara J, Shimojo N, Motohashi S. Aoki T, et al. Among authors: hino m. Pediatr Blood Cancer. 2016 Aug;63(8):1461-4. doi: 10.1002/pbc.26018. Epub 2016 May 2. Pediatr Blood Cancer. 2016. PMID: 27135656 Free PMC article.
ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.
Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K, Yaguchi A, Terada K, Saito Y, Yoshimi A, Ogata-Kawata H, Sakamoto H, Kato M, Fujimura J, Hino M, Kinoshita A, Kakuda H, Kurosawa H, Kato K, Kajiwara R, Moriwaki K, Morimoto T, Nakamura K, Noguchi Y, Osumi T, Sakashita K, Takita J, Yuza Y, Matsuda K, Yoshida T, Matsumoto K, Hata K, Kubo M, Matsubara Y, Fukushima T, Koh K, Manabe A, Ohara A, Kiyokawa N; Tokyo Children’s Cancer Study Group (TCCSG). Hirabayashi S, et al. Among authors: hino m. Haematologica. 2017 Jan;102(1):118-129. doi: 10.3324/haematol.2016.151035. Epub 2016 Sep 15. Haematologica. 2017. PMID: 27634205 Free PMC article.
An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia.
Tanaka Y, Yeoh AEJ, Moriyama T, Li CK, Kudo K, Arakawa Y, Buaboonnam J, Zhang H, Liu HC, Ariffin H, Chen Z, Kham SKY, Nishii R, Hasegawa D, Fujimura J, Keino D, Kondoh K, Sato A, Ueda T, Yamamoto M, Taneyama Y, Hino M, Takagi M, Ohara A, Ito E, Koh K, Hori H, Manabe A, Yang JJ, Kato M. Tanaka Y, et al. Among authors: hino m. Haematologica. 2021 Jul 1;106(7):2026-2029. doi: 10.3324/haematol.2020.266320. Haematologica. 2021. PMID: 33504140 Free PMC article. No abstract available.
Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant.
Ishida H, Tsujimoto SI, Hasegawa D, Sakaguchi H, Yamamoto S, Yanagimachi M, Koh K, Watanabe A, Hama A, Cho Y, Watanabe K, Noguchi M, Takeuchi M, Takita J, Washio K, Kato K, Koike T, Hashii Y, Tabuchi K, Hino M, Atsuta Y, Okamoto Y. Ishida H, et al. Among authors: hino m. Haematologica. 2024 Jan 1;109(1):312-317. doi: 10.3324/haematol.2023.283203. Haematologica. 2024. PMID: 37470138 Free PMC article. No abstract available.
A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Ishida H, Kawahara Y, Tomizawa D, Okamoto Y, Hama A, Cho Y, Koh K, Koga Y, Yoshida N, Sato M, Terui K, Miyagawa N, Watanabe A, Takita J, Kobayashi R, Yamamoto M, Watanabe K, Okada K, Kato K, Matsumoto K, Hino M, Tabuchi K, Sakaguchi H. Ishida H, et al. Among authors: hino m. J Hematol Oncol. 2024 Apr 29;17(1):24. doi: 10.1186/s13045-024-01548-3. J Hematol Oncol. 2024. PMID: 38679709 Free PMC article.
Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma.
Hishiki T, Horie H, Higashimoto Y, Yotsumoto K, Komatsu S, Okimoto Y, Kakuda H, Taneyama Y, Saito T, Terui K, Mitsunaga T, Nakata M, Ochiai H, Hino M, Ando K, Yoshida H, Iwai J. Hishiki T, et al. Among authors: hino m. Pediatr Surg Int. 2014 Sep;30(9):919-26. doi: 10.1007/s00383-014-3564-0. Epub 2014 Jul 27. Pediatr Surg Int. 2014. PMID: 25064228
Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era.
Ishida H, Shimada H, Tanizawa A, Shimazu Y, Tachibana T, Doki N, Ara T, Matsuo Y, Nara M, Toubai T, Ino K, Nakamae H, Kato K, Kato K, Sato A, Hino M, Matsumoto K, Atsuta Y, Yasui M, Nagamura-Inoue T. Ishida H, et al. Among authors: hino m. Am J Hematol. 2023 Aug;98(8):E200-E203. doi: 10.1002/ajh.26959. Epub 2023 May 12. Am J Hematol. 2023. PMID: 37170859
985 results